OMICS FOR LIFE

Welcome to Bumi Genomics

Bumi Genomics Innovation (BGI) is one of the earliest companies which brought in COVID-19 laboratory solution at the early phase of COVID-19 pandemic in Malaysia. BGI is involved in the setup of COVID-19 RT-PCR testing laboratories in Institute of Medical Research, National Institute of Health and Makmal Kesihatan Awam, Kota Kinabalu.

Our Products

Medical Diagnostics

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Lab Instruments

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Supplement

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Our Products

Medical Diagnostics

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Lab Instruments

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Supplement

Lorem ipsum, or lipsum as it is sometimes known, is dummy text used in laying out print, graphic or web designs.

Our Services

NIFTY

NIFTY® (Non-Invasive Fetal TrisomY test) is a safe, simple, non-invasive prenatal test (NIPT), which offers screening for certain genetic conditions from as early as week 10 of pregnancy.

Using the latest genetic sequencing technology, NIFTY® has over >99% accuracy for the three most common trisomy conditions present at birth, which are Down Syndrome, Edwards Syndrome and Patau Syndrome.

SENTIS

BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.

BGI’s Comprehensive Hereditary Cancer Panels provides information on 79 genes associated with 24 different types of hereditary cancer including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, pancreatic, prostate, and stomach cancer. BGI detects different alterations including germline SNV, Indels, and CNV.

Our Brands

Probiotic Supplements

Genomic sequencing services and proteomic services provider

Automated liquid handling system

Diagnostic solutions for healthcare

Natural therapies in combating respiratory infections

Laboratory solution in COVID-19 detection

Life science instruments and reagents

Life science and medical equipment